HPV

GlaxoSmithKline’s European license for Cervarix was amended recently to reflect Cervarix’s success in treating additional strains of human papillomavirus.

Human papillomavirus

The results of a four-year study released on July 20 by the British Medical Journal show that vaccination against certain types of human papillomavirus gives protection against genital warts and pre-cancerous growths of the cervix.

Human papillomavirus

Researchers with QIAGEN said a recent study has shown that Latin American women who used its human papillomavirus test showed improved cervical cancer control when compared to regular cytology testing.

Human papillomavirus

Officials with Dynavax Technologies Corporation announced on July 6 that they were awarded a $600,000 grant from the National Institutes of Health to develop a universal vaccine for human papilloma virus .

Human papillomavirus

Medical experts from across the world are meeting this week in Montreal, Canada, for the 26th annual International Papillomavirus Conference.

The FDA announced last week that it would be extending its review of Merck's application to broaden the age range for Gardasil to include women between the ages of 27 and 45.

Gardasil

FoxNews has reported that only a third of young women are being vaccinated for cervical cancer prevention.

HPV

A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.

HPV

Women older than 40 are unlikely to get much benefit from the vaccine for the virus that causes cervical cancer, a new study reports.

HPV

SAN DIEGO — Inovio Biomedical Corp. announced Feb. 8 additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine trial

HPV

A second vaccine to protect against human papillomavirus, or HPV, has been approved for use in Canada, CBC News reported Feb. 9.

HPV

The number of women under 30 diagnosed with cervical cancer will fall nearly two thirds by 2025 thanks to the vaccine against human papillomavirus, researchers say.

A new study may explain the intense disagreement about proposals to vaccinate elementary-school girls against human papillomavirus, ScienceDaily reported Jan. 14.

HPV

A new study of new couples found that 56 percent of young adults in a new sexual relationship were infected with human papillomavirus, ScienceDaily reported Jan. 14.

Human Papillomavirus

The human papillomavirus (HPV) vaccine Cervarix protects women from infection for longer than six years, new research has found, HealthDay News reported Dec. 2.

Dr. Gemma Kenter

BOSTON — An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the Netherlands reported in a small study Nov. 4.

Dr. Jane Kim

BOSTON — Persistent infection with high-risk types of human papillomavirus, a sexually transmitted virus, is known to be a cause of cervical cancer.

The U.S. Food and Drug Administration announced Oct. 16 that it approved the use of the vaccine Gardasil to prevent genital warts caused by the human papillomavirus types 6 and 11 in males ages 9 to 26.